Legal Opinion
Sanofi-Aventis Deutschland GMBH v. Glenmark Pharmaceuticals Inc.
Court of Appeals for the Federal Circuit
Decided April 21, 2014No. 2012-1489PublishedCited by 12 opinions
1Opinion of the Court
NEWMAN, Circuit Judge.
This patent infringement suit concerns the antihypertension drug having the brand name Tarka®. Tarka® is a combination of two active ingredients into a single dosage product: the angiotensin converting enzyme (ACE) inhibitor tran-dolapril, and the calcium channel blocker (also called “calcium antagonist”) vera-pamil hydrochloride. The combination drug is covered by United States Patent No. 5,721,244 (the '244 patent) and is owned by or exclusively licensed to Sano-fi-Aventis Deutschland GmbH (a company of Germany), Aventis Pharma S.A. (a company of France); Abbott GmbH…
2Cases cited29 opinions
- Chambers v. Nasco, Inc.Supreme Court of the United States · 1991
- Graham v. John Deere Co. of Kansas CitySupreme Court of the United States · 1966
- KSR International Co. v. Teleflex Inc.Supreme Court of the United States · 2007
- Judson C. Brewer v. Quaker State Oil Refining Corporation Quaker State CorporationCourt of Appeals for the Third Circuit · 1995
- Rite-Hite Corp. v. Kelley Co.Court of Appeals for the Federal Circuit · 1995
24 more not listed; retrieve them via the Exa API.
3Cited by12 opinions
- Two-Way Media LLC v. AT & T, Inc.Court of Appeals for the Federal Circuit · 2015
- Novartis AG v. Actavis, Inc.District Court, D. Delaware · 2017
- Bristol-Myers Squibb Company v. Teva Pharmaceuticals USA, IncCourt of Appeals for the Federal Circuit · 2014
- Bristol-Myers Squibb Company v. Teva Pharmaceuticals USA, IncCourt of Appeals for the Federal Circuit · 2014
- Bristol-Myers Squibb Company v. Teva Pharmaceuticals USA, IncCourt of Appeals for the Federal Circuit · 2014
7 more not listed; retrieve them via the Exa API.